chr16-31111229-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_005881.4(BCKDK):c.845+10C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00159 in 1,614,134 control chromosomes in the GnomAD database, including 32 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0088 ( 14 hom., cov: 33)
Exomes 𝑓: 0.00083 ( 18 hom. )
Consequence
BCKDK
NM_005881.4 intron
NM_005881.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.06
Genes affected
BCKDK (HGNC:16902): (branched chain keto acid dehydrogenase kinase) The branched-chain alpha-ketoacid dehydrogenase complex (BCKD) is an important regulator of the valine, leucine, and isoleucine catabolic pathways. The protein encoded by this gene is found in the mitochondrion, where it phosphorylates and inactivates BCKD. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 16-31111229-C-T is Benign according to our data. Variant chr16-31111229-C-T is described in ClinVar as [Benign]. Clinvar id is 128522.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00883 (1345/152276) while in subpopulation AFR AF= 0.0309 (1284/41556). AF 95% confidence interval is 0.0295. There are 14 homozygotes in gnomad4. There are 641 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 14 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BCKDK | NM_005881.4 | c.845+10C>T | intron_variant | ENST00000219794.11 | NP_005872.2 | |||
BCKDK | NM_001122957.4 | c.845+10C>T | intron_variant | NP_001116429.1 | ||||
BCKDK | NM_001271926.3 | c.845+10C>T | intron_variant | NP_001258855.1 | ||||
BCKDK | XM_017022859.2 | c.845+10C>T | intron_variant | XP_016878348.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BCKDK | ENST00000219794.11 | c.845+10C>T | intron_variant | 1 | NM_005881.4 | ENSP00000219794 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00883 AC: 1343AN: 152158Hom.: 14 Cov.: 33
GnomAD3 genomes
AF:
AC:
1343
AN:
152158
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00202 AC: 507AN: 251266Hom.: 9 AF XY: 0.00138 AC XY: 188AN XY: 135806
GnomAD3 exomes
AF:
AC:
507
AN:
251266
Hom.:
AF XY:
AC XY:
188
AN XY:
135806
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000832 AC: 1216AN: 1461858Hom.: 18 Cov.: 32 AF XY: 0.000668 AC XY: 486AN XY: 727228
GnomAD4 exome
AF:
AC:
1216
AN:
1461858
Hom.:
Cov.:
32
AF XY:
AC XY:
486
AN XY:
727228
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00883 AC: 1345AN: 152276Hom.: 14 Cov.: 33 AF XY: 0.00861 AC XY: 641AN XY: 74450
GnomAD4 genome
AF:
AC:
1345
AN:
152276
Hom.:
Cov.:
33
AF XY:
AC XY:
641
AN XY:
74450
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Likely benign, no assertion criteria provided | clinical testing | Genetic Services Laboratory, University of Chicago | - | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Aug 31, 2017 | - - |
Branched-chain keto acid dehydrogenase kinase deficiency Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 12, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at